MedPath

Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow

Conditions
Haemodialysis
Registration Number
NCT02902848
Lead Sponsor
University Hospital, Brest
Brief Summary

The purpose of this study is to evaluate the INR value of hemodialyzed patient coagulation state (prothrombin time) measured inside the therapeutical zone and thanks to a portable monitor. The values obtained at the point of care will be compared to the standard biological assessment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age > 18
  • Haemodialyzed patient whose INR needs to be monitored
  • Patient not objecting to participate in the study
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
correlation ratio between point-of-care PT/INR value and standard laboratory assessement5 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Brest

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath